2022 Scientific Advisory Committee

Otis W. Brawley, M.D., MACP, FASCO, FACE
Bloomberg Distinguished Professor of Oncology and Epidemiology
Johns Hopkins University
1550 Orleans St
CRB 1M-14
Baltimore, MD 21287, Otis.Brawley@JHU.edu

Michael J. Cima, Ph.D.
Professor
David H. Koch Professor of Engineering
Faculty Director of the Lemelson-MIT Program
Department of Materials Science and Engineering
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology
77 Massachusetts Avenue
Bldg 76 Room 653G
Cambridge MA 02139
617-253-6877, mjcima@mit.edu

Alan D'Andrea, M.D.
Director, Susan F. Smith Center for Women's Cancers
The Fuller-American Cancer Society
Professor, Dana-Faber Cancer Institute
450 Brookline Avenue, HIM 243
Boston, MA 02115
(617) 632-2080, alan_dandrea@dfci.harvard.edu

Mark Manfredi, Ph.D.
Chief Scientific Officer
Kyn Therapeutics
400 Technology Square 10th Floor
Cambridge, MA 02139
(857) 201-2764, mark@kyntherapeutics.com

​​Olufunmilayo Olopade, M.B.B.S., F.A.ACR.
Professor of Medicine and Human Genetics
The University of Chicago
5841 S Maryland Avenue, MC 2115
Chicago, IL  60637
(773) 702-1632, folopade@medicine.bsd.uchicago.edu

Drew M. Pardoll M.D., Ph.D.
Abeloff Professor of Oncology
Director, Bloomberg~Kimmel Institute for Cancer Immunotherapy
Director, Cancer Immunology Program
The Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University School of Medicine
1650 Orleans Street, CRB1 Room 444
Baltimore, MD 21287
(410) 955-7866, dpardol1@jhmi.edu

William L. Dahut, M.D.
Chief Scientific Officer
American Cancer Society, Inc.
655 15th Street NW Suite 503
Washington, DC 20005
 (800)227-2345, William.dahu@cancer.org

Tona M. Gilmer, Ph.D.
C-Founder & CSO
XRad Therapeutics
3211 Moores Mill Rd.
Rougemont, NC 27572
(919) 412-7377, tgilmer10@gmail.com

Peter A. Jones, Ph.D., D.Sc.
Chief Scientific Officer
Van Andel Research Institute
333 Bostwick Ave., N.E.
Grand Rapids, Michigan 49503
(616) 234-5685, peter.jones@vai.org

Carl June, M.D.
Richard W. Vague Professor
in Immunotherapy
University of Pennsylvania
409 Baird Road
Merion, PA 19066
(215) 573-3269, cjune@upenn.edu

William G. Kaelin, Jr., M.D.
Sidney Farber Professor of Medicine
Dana-Farber Cancer Institute and
Howard Hughes Medical Institute
450 Brookline Avenue, Mayer 457
Boston, MA 02115
(617) 632-3975, william_kaelin@dfci.harvard.edu

Michael B. Kastan, M.D., Ph.D.
Executive Director
Duke Cancer Institute
Mail Box 3917
10 Bryan Searle Drive
Seeley Mudd Building
Durham, NC 27710
(919) 684-3052, michael.kastan@duke.edu

Karen E. Knudsen, MBA, Ph.D.
Chief Executive Officer
American Cancer Society, Inc.
1818 Market Street
Philadelphia, PA  19103
(800)227-2345, karen.knudsen@cancer.org

Scott W. Lowe, Ph.D.
Chair, Cancer Biology & Genetics Program, MSKCC
Memorial Sloan Kettering Cancer Center
1275 York Avenue, Box 373
New York, NY 10065
(646) 888-3342, lowes@mskcc.org

Robert Radinsky, Ph.D.
Vice President, Oncology Scientific Innovations
Janssen Research & Development
255 Main Street, 7th floor
Cambridge, MA 02142
(215) 450-6110, rradinsk@its.jnj.com

Mark Rolfe, Ph.D.
Corporate Vice President
Protein Homeostasis Research & Early Development
Celgene Corporation
(415) 876-8300, mrolfe@celgene.com

Christian Rommel, Ph.D.
Global Head Oncology
Roche Pharma Research and Early Development
Roche Innovation Center Basel
F. Hoffmann-La Roche Ltd
Grenzacherstrasse 124 (B.52, R.11.04)
CH-4070 Basel
Switzerland
+41 61 682 18 34, Christian.rommel@roche.com

Brid M. Ryan, Ph.D., MPH
Vice President of Immune-Oncology Research
MiNA Therapeutics
36 Bassett Road
London, W106JL
United Kingdom
+44-7824453556, bridmryan.gmail.com

Suzanne Topalian, M.D.
Professor, Johns Hopkins University School of Medicine
1550 Orleans St., CRB2-508
Baltimore, MD 21287
(410) 502-8218, stopali1@jhmi.edu

James Allison, Ph.D.
Emeritus

​Stephen Chanock, M.D.
Emeritus

William H. Farland, Ph.D.
Emeritus

Levi A. Garraway, M.D., Ph.D.
Emeritus

​David G. Kaufman, M.D., Ph.D.
Emeritus

Stuart H. Yuspa, M.D.
Emeritus